D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells
D-2-hydroxyglutarate (D-2-HG) accumulates in patients with acute myeloid leukemia (AML) with mutated isocitrate dehydrogenase (IDH) and in other malignancies. D-2-HG suppresses antitumor T-cell immunity but little is known about potential effects on non-malignant myeloid cells. Here we show that D-2...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
August, 2024
|
| In: |
Haematologica
Year: 2024, Jahrgang: 109, Heft: 8, Pages: 2500-2514 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2023.283597 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3324/haematol.2023.283597 Verlag, lizenzpflichtig, Volltext: https://haematologica.org/article/view/haematol.2023.283597 
|
| Verfasserangaben: | Kathrin Hammon, Kathrin Renner, Michael Althammer, Florian Voll, Nathalie Babl, Sonja-Maria Decking, Peter J. Siska, Carina Matos, Zugey Elizabeth Cárdenas Conejo, Karina Mendes, Friederike Einwag, Heiko Siegmund, Sabine Iberl, Raffaela S. Berger, Katja Dettmer, Rebecca Schoenmehl, Christoph Brochhausen, Wolfgang Herr, Peter J. Oefner, Michael Rehli, Simone Thomas, Marina Kreutz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1921329610 | ||
| 003 | DE-627 | ||
| 005 | 20250717004623.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250403s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2023.283597 |2 doi | |
| 035 | |a (DE-627)1921329610 | ||
| 035 | |a (DE-599)KXP1921329610 | ||
| 035 | |a (OCoLC)1528044104 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hammon, Kathrin |e VerfasserIn |0 (DE-588)1362227439 |0 (DE-627)1921329963 |4 aut | |
| 245 | 1 | 0 | |a D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells |c Kathrin Hammon, Kathrin Renner, Michael Althammer, Florian Voll, Nathalie Babl, Sonja-Maria Decking, Peter J. Siska, Carina Matos, Zugey Elizabeth Cárdenas Conejo, Karina Mendes, Friederike Einwag, Heiko Siegmund, Sabine Iberl, Raffaela S. Berger, Katja Dettmer, Rebecca Schoenmehl, Christoph Brochhausen, Wolfgang Herr, Peter J. Oefner, Michael Rehli, Simone Thomas, Marina Kreutz |
| 246 | 3 | 3 | |a D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class two expression in non-malignant dendritic cells and acute myeloid leukemia cells |
| 264 | 1 | |c August, 2024 | |
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.04.2025 | ||
| 520 | |a D-2-hydroxyglutarate (D-2-HG) accumulates in patients with acute myeloid leukemia (AML) with mutated isocitrate dehydrogenase (IDH) and in other malignancies. D-2-HG suppresses antitumor T-cell immunity but little is known about potential effects on non-malignant myeloid cells. Here we show that D-2-HG impairs human but not murine dendritic cell differentiation, resulting in a tolerogenic phenotype with low major histocompatibility class II expression. In line with this, IDH-mutated AML blasts exhibited lower expression of HLA-DP and were less susceptible to lysis by HLA-DP-specific T cells. Interestingly, besides its expected impact on DNA demethylation, D-2-HG reprogrammed metabolism towards increased lactate production in dendritic cells and AML. Vitamin C accelerated DNA demethylation, but only the combination of vitamin C and glycolytic inhibition lowered lactate levels and supported major histocompatibility complex class II expression. Our results indicate an unexpected link between the immunosuppressive metabolites 2-HG and lactic acid and suggest a potentially novel therapeutic strategy with combinations of anti-glycolytic drugs and epigenetic modulators (hypomethylating agents) or other therapeutics for the treatment of AML. | ||
| 700 | 1 | |a Renner, Kathrin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Althammer, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Voll, Florian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Babl, Nathalie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Decking, Sonja-Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Siska, Peter J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Matos, Carina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Conejo, Zugey Elizabeth Cárdenas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mendes, Karina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Einwag, Friederike |e VerfasserIn |4 aut | |
| 700 | 1 | |a Siegmund, Heiko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Iberl, Sabine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berger, Raffaela S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dettmer, Katja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schönmehl, Rebecca |d 1991- |e VerfasserIn |0 (DE-588)1324477970 |0 (DE-627)1884336949 |4 aut | |
| 700 | 1 | |a Brochhausen, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Herr, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Oefner, Peter J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rehli, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thomas, Simone |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kreutz, Marina |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica |d Pavia : Ferrata Storti Foundation, 2014 |g 109(2024), 8 vom: Aug., Seite 2500-2514 |h Online-Ressource |w (DE-627)814204899 |w (DE-600)2805244-4 |w (DE-576)424051125 |x 1592-8721 |7 nnas |a D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells |
| 773 | 1 | 8 | |g volume:109 |g year:2024 |g number:8 |g month:08 |g pages:2500-2514 |g extent:15 |a D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells |
| 856 | 4 | 0 | |u https://doi.org/10.3324/haematol.2023.283597 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://haematologica.org/article/view/haematol.2023.283597 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250403 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1324477970 |a Schönmehl, Rebecca |m 1324477970:Schönmehl, Rebecca |d 60000 |d 63400 |e 60000PS1324477970 |e 63400PS1324477970 |k 0/60000/ |k 1/60000/63400/ |p 16 | ||
| 999 | |a KXP-PPN1921329610 |e 469693330X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Hammon","given":"Kathrin","display":"Hammon, Kathrin","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Renner, Kathrin","given":"Kathrin","family":"Renner"},{"role":"aut","display":"Althammer, Michael","roleDisplay":"VerfasserIn","given":"Michael","family":"Althammer"},{"family":"Voll","given":"Florian","roleDisplay":"VerfasserIn","display":"Voll, Florian","role":"aut"},{"role":"aut","display":"Babl, Nathalie","roleDisplay":"VerfasserIn","given":"Nathalie","family":"Babl"},{"family":"Decking","given":"Sonja-Maria","roleDisplay":"VerfasserIn","display":"Decking, Sonja-Maria","role":"aut"},{"display":"Siska, Peter J.","roleDisplay":"VerfasserIn","role":"aut","family":"Siska","given":"Peter J."},{"family":"Matos","given":"Carina","display":"Matos, Carina","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Conejo, Zugey Elizabeth Cárdenas","role":"aut","family":"Conejo","given":"Zugey Elizabeth Cárdenas"},{"role":"aut","display":"Mendes, Karina","roleDisplay":"VerfasserIn","given":"Karina","family":"Mendes"},{"given":"Friederike","family":"Einwag","role":"aut","roleDisplay":"VerfasserIn","display":"Einwag, Friederike"},{"given":"Heiko","family":"Siegmund","role":"aut","roleDisplay":"VerfasserIn","display":"Siegmund, Heiko"},{"role":"aut","display":"Iberl, Sabine","roleDisplay":"VerfasserIn","given":"Sabine","family":"Iberl"},{"given":"Raffaela S.","family":"Berger","role":"aut","roleDisplay":"VerfasserIn","display":"Berger, Raffaela S."},{"family":"Dettmer","given":"Katja","display":"Dettmer, Katja","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Rebecca","family":"Schönmehl","role":"aut","roleDisplay":"VerfasserIn","display":"Schönmehl, Rebecca"},{"given":"Christoph","family":"Brochhausen","role":"aut","display":"Brochhausen, Christoph","roleDisplay":"VerfasserIn"},{"given":"Wolfgang","family":"Herr","role":"aut","display":"Herr, Wolfgang","roleDisplay":"VerfasserIn"},{"display":"Oefner, Peter J.","roleDisplay":"VerfasserIn","role":"aut","family":"Oefner","given":"Peter J."},{"given":"Michael","family":"Rehli","role":"aut","display":"Rehli, Michael","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Thomas, Simone","roleDisplay":"VerfasserIn","given":"Simone","family":"Thomas"},{"role":"aut","display":"Kreutz, Marina","roleDisplay":"VerfasserIn","given":"Marina","family":"Kreutz"}],"title":[{"title":"D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells","title_sort":"D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 03.04.2025"],"language":["eng"],"recId":"1921329610","titleAlt":[{"title":"D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class two expression in non-malignant dendritic cells and acute myeloid leukemia cells"}],"name":{"displayForm":["Kathrin Hammon, Kathrin Renner, Michael Althammer, Florian Voll, Nathalie Babl, Sonja-Maria Decking, Peter J. Siska, Carina Matos, Zugey Elizabeth Cárdenas Conejo, Karina Mendes, Friederike Einwag, Heiko Siegmund, Sabine Iberl, Raffaela S. Berger, Katja Dettmer, Rebecca Schoenmehl, Christoph Brochhausen, Wolfgang Herr, Peter J. Oefner, Michael Rehli, Simone Thomas, Marina Kreutz"]},"origin":[{"dateIssuedDisp":"August, 2024","dateIssuedKey":"2024"}],"id":{"doi":["10.3324/haematol.2023.283597"],"eki":["1921329610"]},"physDesc":[{"extent":"15 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1592-8721"],"eki":["814204899"],"zdb":["2805244-4"]},"origin":[{"publisherPlace":"Pavia","dateIssuedKey":"2014","publisher":"Ferrata Storti Foundation","dateIssuedDisp":"2014-"}],"part":{"issue":"8","pages":"2500-2514","year":"2024","extent":"15","volume":"109","text":"109(2024), 8 vom: Aug., Seite 2500-2514"},"titleAlt":[{"title":"journal of the European Hematology Association"}],"pubHistory":["99.2014 -"],"recId":"814204899","language":["eng"],"disp":"D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cellsHaematologica","note":["Gesehen am 27.05.2022"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"Haematologica","title":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation"}]}]} | ||
| SRT | |a HAMMONKATHD2HYDROXYG2024 | ||